Literature DB >> 8817577

Spatial learning and hippocampal long-term potentiation are not impaired in mdx mice.

A K Sesay1, M L Errington, L Levita, T V Bliss.   

Abstract

Moderate non-progressive cognitive impairment is a consistent feature of Duchenne muscular dystrophy (DMD), although few central nervous system abnormalities have yet been identified. A model for DMD is provided by the mdx mouse which fails to produce full length dystrophin in muscle and brain. In this study we have compared performances in a hippocampal-dependent spatial learning task, the Morris water maze, in mdx mice and in age-matched normal (C57BL/10) mice. There was no difference in acquisition rates or in retention between the two groups. We also found no difference in the magnitude of long-term potentiation (LTP) between the two groups, either in the dentate gyrus or in area CA. These experiments demonstrate that neither spatial learning nor hippocampal synaptic plasticity are significantly affected by the lack of full-length dystrophin.

Entities:  

Mesh:

Year:  1996        PMID: 8817577     DOI: 10.1016/0304-3940(96)12747-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Dysregulation of Intracellular Ca2+ in Dystrophic Cortical and Hippocampal Neurons.

Authors:  José R Lopez; Juan Kolster; Arkady Uryash; Eric Estève; Francisco Altamirano; José A Adams
Journal:  Mol Neurobiol       Date:  2016-12-15       Impact factor: 5.590

Review 2.  Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.

Authors:  Mark G Rae; Dervla O'Malley
Journal:  J Neurophysiol       Date:  2016-07-06       Impact factor: 2.714

3.  Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy.

Authors:  Bo Deng; David Glanzman; James G Tidball
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

Review 4.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17

5.  Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons.

Authors:  Jose R Lopez; A Uryash; J Kolster; E Estève; R Zhang; J A Adams
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

Review 6.  Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies.

Authors:  Akshay Anand; Rahul Tyagi; Manju Mohanty; Manoj Goyal; K Ranil D De Silva; Nalaka Wijekoon
Journal:  Ann Neurosci       Date:  2015-04

7.  In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy.

Authors:  Trace L Stay; Lauren N Miterko; Marife Arancillo; Tao Lin; Roy V Sillitoe
Journal:  Dis Model Mech       Date:  2019-12-09       Impact factor: 5.758

Review 8.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

9.  Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy.

Authors:  Bauke Kogelman; Artem Khmelinskii; Ingrid Verhaart; Laura van Vliet; Diewertje I Bink; Annemieke Aartsma-Rus; Maaike van Putten; Louise van der Weerd
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

Review 10.  Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy.

Authors:  Michael Naidoo; Karen Anthony
Journal:  Mol Neurobiol       Date:  2019-12-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.